Certified by Founder Lodge
Ataraxis AI
United States - New York, NY
START UP
1 Disclosed Funding Rounds $4,000,000
0 Participating Investments
-
Founded date
2023
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Ataraxis is an AI precision medicine company transforming cancer diagnostics and patient outcomes through the power of AI. We are addressing previously unsolvable problems in cancer prognosis
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 01 ,2024 | Seed | $4,000,000 |
Giant Ventures
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Humble Robotics | $24,000,000 | (Apr 22, 2026)
Sinai.ai | $1,450,000 | (Apr 22, 2026)
NeoCognition | $40,000,000 | (Apr 22, 2026)
Qualitate | $7,000,000 | (Apr 22, 2026)
Deep Blue Medical Advances, Inc. | $5,600,000 | (Apr 22, 2026)
